| scholarly article | Q13442814 |
| P2093 | author name string | Frank R | |
| Frosch M | |||
| Vogel U | |||
| Müller A | |||
| Weinberger A | |||
| Atkinson JP | |||
| Köhl J | |||
| P2860 | cites work | Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. | Q54177285 |
| Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. | Q54453907 | ||
| Antibodies to N‐terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated | Q67464602 | ||
| Analysis of C3 deposition and degradation on bacterial surfaces after opsonization | Q68128527 | ||
| Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway | Q68873197 | ||
| Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid | Q69245459 | ||
| The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis | Q70826630 | ||
| The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation | Q71071247 | ||
| SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes | Q71873230 | ||
| Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals | Q28290497 | ||
| Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria | Q33616834 | ||
| Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B | Q33841587 | ||
| Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity | Q34547078 | ||
| Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. | Q35421789 | ||
| Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing | Q35458135 | ||
| Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae | Q35513855 | ||
| Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance | Q35587941 | ||
| Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae. | Q35779576 | ||
| Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation | Q35899072 | ||
| Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis | Q36145701 | ||
| Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci | Q36951376 | ||
| Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis | Q36953132 | ||
| Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils | Q36955918 | ||
| Deposition and degradation of C3 on type III group B streptococci | Q36964654 | ||
| Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii | Q37022345 | ||
| Complement evasion by bacteria and parasites | Q39548229 | ||
| Activation of the complement system by pathogenic fungi | Q39820650 | ||
| Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation | Q40162311 | ||
| Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice | Q40176406 | ||
| Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns | Q40181929 | ||
| Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing | Q40182051 | ||
| Recognition and control of neisserial infection by antibody and complement. | Q40455856 | ||
| Complement deficiency states and meningococcal disease | Q40804745 | ||
| Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. | Q40825138 | ||
| Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. | Q41063588 | ||
| Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity | Q41147868 | ||
| The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide | Q41556908 | ||
| Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine | Q43496518 | ||
| Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. | Q43641259 | ||
| C4B deficiency: a risk factor for bacteremia with encapsulated organisms | Q46603538 | ||
| Human IgA1 initiates complement-mediated killing of Neisseria meningitidis | Q46912472 | ||
| Meningococcal pilin: a glycoprotein substituted with digalactosyl 2,4-diacetamido-2,4,6-trideoxyhexose | Q48070795 | ||
| Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. | Q48084641 | ||
| Binding of mannan-binding protein to various bacterial pathogens of meningitis | Q50147158 | ||
| Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. | Q52559536 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Neisseria meningitidis | Q154625 |
| P304 | page(s) | 4022-4029 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis | |
| P478 | volume | 65 |
| Q39143108 | A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA). |
| Q64106983 | A homopolymeric adenosine tract in the promoter region of nspA influences factor H-mediated serum resistance in Neisseria meningitidis |
| Q36400453 | A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae |
| Q92156626 | Atypical, Yet Not Infrequent, Infections with Neisseria Species |
| Q36402993 | Available carbon source influences the resistance of Neisseria meningitidis against complement |
| Q33958765 | Bacterial avoidance of phagocytosis. |
| Q42911223 | Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases |
| Q37727051 | Biofilm formation by the human pathogen Neisseria meningitidis |
| Q33768892 | CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells |
| Q41774048 | Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity |
| Q33685515 | Clinical and laboratory evidence for Neisseria meningitidis biofilms |
| Q34796849 | Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups. |
| Q39667409 | Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence |
| Q39655597 | Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity |
| Q38322923 | Decoration of Histophilus somni lipooligosaccharide with N-acetyl-5-neuraminic acid enhances bacterial binding of complement factor H and resistance to killing by serum and polymorphonuclear leukocytes |
| Q36422066 | Defining targets for complement components C4b and C3b on the pathogenic neisseriae |
| Q35888059 | Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen |
| Q37401428 | Factor H and neisserial pathogenesis |
| Q37191341 | Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin |
| Q35833811 | Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo |
| Q24534699 | Identification of a novel sialic acid transporter in Haemophilus ducreyi |
| Q35637385 | Identification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI. |
| Q35689380 | Lactate acquisition promotes successful colonization of the murine genital tract by Neisseria gonorrhoeae |
| Q33599918 | Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum |
| Q37531325 | Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development |
| Q34376170 | Meningococcal disease and the complement system |
| Q34624357 | Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement |
| Q35063071 | Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H. |
| Q35554124 | Molecular mimicry of host structures by lipooligosaccharides of Neisseria meningitidis: characterization of sialylated and nonsialylated lacto-N-neotetraose (Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc) structures in lipooligosaccharides using monoclonal a |
| Q37523580 | Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity |
| Q36888510 | Neisseria meningitidis Polynucleotide Phosphorylase Affects Aggregation, Adhesion, and Virulence |
| Q41601349 | NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus |
| Q34428168 | Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci |
| Q34116680 | Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro |
| Q77566070 | Polysialic acid: three-dimensional structure, biosynthesis and function |
| Q33946852 | Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis |
| Q35046832 | Revisiting the host as a growth medium |
| Q41459015 | Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3. |
| Q34006932 | Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A. |
| Q39509812 | Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. |
| Q34071034 | Sialic acid involved in hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with resistance to neutrophil phagocytosis. |
| Q42863338 | Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression |
| Q34005157 | Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni |
| Q99575141 | Structural and Biosynthetic Diversity of Nonulosonic Acids (NulOs) That Decorate Surface Structures in Bacteria |
| Q33769638 | The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum |
| Q33798900 | The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition |
| Q33852676 | The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. |
| Q34208951 | The interplay between Siglecs and sialylated pathogens |
| Q36340099 | Transcriptomic buffering of cryptic genetic variation contributes to meningococcal virulence |
| Q92765243 | Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation |
| Q35072338 | α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract |
Search more.